Skip to content

MR Fingerprinting for Vestibular Schwannomas

MR-Fingerprinting for the Prediction of the Response of Vestibular Schwannomas to Gamma Knife Radiosurgery

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04851925
Enrollment
50
Registered
2021-04-21
Start date
2021-02-24
Completion date
2025-12-24
Last updated
2024-01-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Vestibular Schwannoma

Brief summary

MR Fingerprinting (MRF) will be performed in patients who will be treated with Gamma Knife radio surgery for a vestibular schwannoma before the intervention. Fifty patients will be included with a vestibular schwannoma of minimum 1cm in size. During follow-up, response of the tumor to radiosurgery will be evaluated for each patient with MRI. The aim of the study is to find patterns of vestibular schwannomas in MRF data which correlate with the type of response to radio surgery, i.e. tumor control after radiosurgery, further tumor growth despite radiosurgery, cystic transformation after radiosurgery.

Interventions

Specific Magnetic Resonance Imaging protocol

Sponsors

Medical University of Vienna
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 90 Years

Inclusion criteria

Planned Gamma Knife radiosurgery for vestibular schwannoma of minimum 1cm in size -

Exclusion criteria

Vestibular Schwannoma of less than 1cm in size. Other a priori treatment than Gamma Knife radiosurgery \-

Design outcomes

Primary

MeasureTime frameDescription
Tumor control3 yearsNumber of patients without further growth of the tumor on follow-up MRI after radiosurgery
Tumor growth3 yearsNumber of patients with growth of the tumor on follow-up MRI after radiosurgery
Cystic transformation3 yearsNumber of patients with cystic transformation of the tumor on follow-up MRI after radiosurgery

Countries

Austria

Contacts

Primary ContactDorian Hirschmann, MD
dorian.hirschmann@meduniwien.ac.at+4314040025780
Backup ContactJosa Frischer, MD
josa.frischer@meduniwien.ac.at+4314040045500

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026